Virus Genes

, Volume 35, Issue 2, pp 155–159

Genetic analysis of HAV strains in Tunisia reveals two new antigenic variants

  • Hakima Gharbi-Khelifi
  • Khira Sdiri
  • Rafik Harrath
  • Lamia Fki
  • Hèla Hakim
  • Mathilde Berthomé
  • Sylviane Billaudel
  • Virginie Ferre
  • Mahjoub Aouni
Article

DOI: 10.1007/s11262-007-0093-0

Cite this article as:
Gharbi-Khelifi, H., Sdiri, K., Harrath, R. et al. Virus Genes (2007) 35: 155. doi:10.1007/s11262-007-0093-0

Abstract

To evaluate the genetic variability of hepatitis A virus (HAV) isolates in Tunisia, serum samples were collected from 99 patients in different Tunisian areas in 2003 containing 92 cases with acute hepatitis, five with severe acute hepatitis and two with fulminant hepatitis. The entire VP1 gene was amplified and sequenced. Sequences were then aligned and a phylogenetic analysis was performed. Additionally, the amino acid (aa) sequence of the VP1 was determined. The analysis of Tunisian HAV isolates revealed that all the isolates were sub-genotype IA with 96.4%–99.8% of identity and showed the emergence of two novel antigenic variants. The Tun31-03 antigenic variant, with a 38 aa deletion containing Met156, Val171, Leu174 and Ala176 and located between 150 and 187 aa of the VP1 protein where neutralization escape mutations, was found. The second antigenic variant, Tun36-03, was isolated from a patient with fulminant hepatitis and presented a substitution of Thr by Pro at position 10 of the VP1 protein. This amino acid is located in a peptide presenting an antigenically reactive epitope of the VP1 protein. This substitution has never been described previously.

Keywords

Hepatitis A VirusVP1 proteinAmino acidAntigenic variants

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Hakima Gharbi-Khelifi
    • 1
    • 2
  • Khira Sdiri
    • 1
  • Rafik Harrath
    • 1
  • Lamia Fki
    • 3
  • Hèla Hakim
    • 3
  • Mathilde Berthomé
    • 2
  • Sylviane Billaudel
    • 2
  • Virginie Ferre
    • 2
  • Mahjoub Aouni
    • 1
  1. 1.Laboratoire des Maladies Transmissibles et Substances Biologiquement Actives, Faculté de Pharmacie de MonastirMonastirTunisia
  2. 2.JE 2437, Département de MicrobiologieFaculté de PharmacieNantesFrance
  3. 3.Laboratorie de Virologie, CHU Habib BourguibaSfaxTunisia